AngioDynamics, Inc. - Common Stock (NQ:ANGO)

11.23 -2.96 (-20.86%)

Delayed Quote Updated: 4:00 PM EDT, Oct 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AngioDynamics, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

AngioDynamics' Q4 Top-Line Beats Street View, Issues Mixed FY23 Guidance ↗

July 12, 2022

Via Benzinga

Recap: AngioDynamics Q4 Earnings ↗

July 12, 2022

AngioDynamics (NASDAQ:ANGO) reported its Q4 earnings results on Tuesday, July 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings AngioDynamics reported in-line...

Via Benzinga

AngioDynamics Reports Fiscal Year 2022 Fourth Quarter and Full-Year Financial Results; Issues Fiscal Year 2023 Guidance

July 12, 2022

From AngioDynamics, Inc.

Via Business Wire

U.S. Stock Futures Down Ahead Of PepsiCo Earnings ↗

July 12, 2022

Pre-open movers

Via Benzinga

Earnings Scheduled For July 12, 2022 ↗

July 12, 2022

Companies Reporting Before The Bell • AngioDynamics (NASDAQ:ANGO) is estimated to report quarterly earnings at $0.01 per share on revenue of $83.25 million.

Via Benzinga

AngioDynamics Posts Wider Q3 Loss On Higher Costs, Reaffirms FY22 Outlook ↗

April 07, 2022

Via Benzinga

PepsiCo, GameStop And 3 Stocks To Watch Heading Into Tuesday ↗

July 12, 2022

With the US stock futures trading lower this morning on Tuesday after the Nasdaq recorded sharp losses in the previous session, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

Earnings Preview: AngioDynamics ↗

July 11, 2022

AngioDynamics (NASDAQ:ANGO) is set to give its latest quarterly earnings report on Tuesday, 2022-07-12. Here's what investors need to know before the announcement. Analysts estimate that AngioDynamics...

Via Benzinga

AngioDynamics to Report Fiscal 2022 Fourth Quarter and Full-Year Financial Results on July 12, 2022

June 15, 2022

From AngioDynamics, Inc.

Via Business Wire

AngioDynamics to Present at the UBS Global Healthcare Conference

May 16, 2022

From AngioDynamics, Inc.

Via Business Wire

AngioDynamics to Present at the BofA Securities Healthcare Conference

May 03, 2022

From AngioDynamics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 07, 2022

Gainers IMAC Holdings (NASDAQ:IMAC) shares increased by 60.0% to $1.6 during Thursday's pre-market session. The market value of their outstanding shares is at $41.9 million.

Via Benzinga

The Daily Biotech Pulse: Pfizer Goes Shopping, AstraZeneca Inks Bispecific Antibody Deal, Aptinyx Faces Clinical Study Setback, Erytech Jumps On Data And More ↗

April 07, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

AngioDynamics Reports Fiscal 2022 Third Quarter Financial Results; Reaffirms Fiscal Year 2022 Guidance

April 07, 2022

From AngioDynamics, Inc.

Via Business Wire

Earnings Scheduled For April 7, 2022 ↗

April 07, 2022

Companies Reporting Before The Bell • Cazoo Gr (NYSE:CZOO) is likely to report earnings for its fourth quarter.

Via Benzinga

AngioDynamics's Earnings: A Preview ↗

April 06, 2022

AngioDynamics (NASDAQ:ANGO) is set to give its latest quarterly earnings report on Thursday, 2022-04-07. Here's what investors need to know before the announcement. Analysts estimate that AngioDynamics...

Via Benzinga

AngioDynamics's Earnings Outlook ↗

April 06, 2022

Via Benzinga

A Preview Of AngioDynamics's Earnings ↗

April 06, 2022

Via Benzinga

AngioDynamics to Present at the Needham Virtual Healthcare Conference

April 04, 2022

From AngioDynamics, Inc.

Via Business Wire

The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight ↗

April 03, 2022

Biopharma stocks outperformed the broader market in the week ending April 2, thereby recouping the losses from the previous week. Clinical readouts and FDA decisions were among the chief catalysts that...

Via Benzinga

AngioDynamics to Report Fiscal 2022 Third Quarter Financial Results on April 7, 2022

March 14, 2022

From AngioDynamics, Inc.

Via Business Wire

AngioDynamics to Present at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

February 08, 2022

From AngioDynamics, Inc.

Via Business Wire

4 Stocks Insiders Are Buying ↗

January 13, 2022

When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, t...

Via Benzinga

AngioDynamics Earnings Perspective: Return On Capital Employed ↗

January 07, 2022

According to Benzinga Pro data, during Q1, AngioDynamics (NASDAQ:ANGO) posted sales of $76.97 million. Earnings were up 64.19%, but AngioDynamics still reported an overall loss of...

Via Benzinga

AngioDynamics Reports Fiscal 2022 Second Quarter Financial Results; Reaffirms Revenue Guidance; Revises Gross Margin and Adjusted EPS Guidance

January 06, 2022

From AngioDynamics, Inc.

Via Business Wire

Earnings Scheduled For January 6, 2022 ↗

January 06, 2022

Companies Reporting Before The Bell • Northern Technologies (NASDAQ:NTIC) is estimated to report quarterly earnings at $0.18 per share on revenue of $16.90 million....

Via Benzinga

AngioDynamics to Present at the Needham Virtual Growth Conference

January 03, 2022

From AngioDynamics, Inc.

Via Business Wire

The Week Ahead In Biotech (Jan. 2-Jan. 8): Stray Clinical Readouts In Focus In Slow News Week ↗

January 02, 2022

Biotech stocks came under selling pressure in the final week of 2021, although they carved out modest gains for the year. Here are the key catalysts that can sway biotech stocks in the unfolding week.

Via Talk Markets

AngioDynamics to Report Fiscal 2022 Second Quarter Financial Results on January 6, 2022

December 15, 2021

From AngioDynamics, Inc.

Via Business Wire

Is This Under-the-Radar Medical Devices Stock a Buy? ↗

November 03, 2021

The medical devices company beat analyst expectations in the first quarter of its new fiscal year. Could it be a buy?

Via The Motley Fool

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.